What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent

BACKGROUND AND PURPOSE: Despite the label change and the FDA's boxed warning added to the Feraheme (ferumoxytol) label in March 2015, radiologists have shown increasing interest in using ferumoxytol as an MR imaging contrast agent as a supplement or alternative to gadolinium. The goals of this...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:AJNR Am J Neuroradiol
Prif Awduron: Varallyay, C.G., Toth, G.B., Fu, R., Netto, J.P., Firkins, J., Ambady, P., Neuwelt, E.A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Neuroradiology 2017
Pynciau:
Patient Safety
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5509484/
https://ncbi.nlm.nih.gov/pubmed/28495944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A5188
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg